Advances of nanomaterials-based strategies for fighting against COVID-19

Chunxi Zeng1, Xucheng Hou1, Margaret Bohmer2

  • 1Division of Pharmaceutics & Pharmacology, College of Pharmacy The Ohio State University Columbus Ohio USA.

View (Beijing, China)
|November 12, 2021
PubMed

Insights

Nanomaterials offer rapid diagnostics, accelerated vaccine development, and novel treatments to combat the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. These advanced materials are crucial in controlling the spread and impact of coronavirus disease 2019 (COVID-19).

Area of Science:

  • Materials Science
  • Nanotechnology
  • Infectious Diseases
  • Immunology

Background:

  • The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has caused widespread global health challenges.
  • Decades of research in nanomaterials have paved the way for innovative applications in combating infectious diseases.

Purpose of the Study:

  • To provide an overview of nanomaterials-based strategies for diagnostics, vaccines, and therapeutics against SARS-CoV-2.
  • To highlight the significant role of nanomaterials in addressing the COVID-19 pandemic.

Main Methods:

  • Review of existing literature on nanomaterials applications in COVID-19.
  • Categorization of nanomaterials-based approaches into diagnostics, vaccines, and therapeutics.

Main Results:

  • Nanomaterials enable rapid, low-cost diagnostic assays for SARS-CoV-2 detection.
  • Nanomaterials facilitate efficient antigen delivery and adjuvant functions for accelerated vaccine development.
  • Nanomaterials-based therapeutics show potential in inhibiting viral replication and reducing inflammation.

Conclusions:

  • Nanomaterials are pivotal in developing diagnostics, vaccines, and therapeutics for COVID-19.
  • The application of nanomaterials has been instrumental in controlling the COVID-19 pandemic.
  • Continued research in nanomaterials holds promise for future pandemic preparedness.

Related Concept Videos